IN2014DE03239A - - Google Patents

Info

Publication number
IN2014DE03239A
IN2014DE03239A IN3239DE2014A IN2014DE03239A IN 2014DE03239 A IN2014DE03239 A IN 2014DE03239A IN 3239DE2014 A IN3239DE2014 A IN 3239DE2014A IN 2014DE03239 A IN2014DE03239 A IN 2014DE03239A
Authority
IN
India
Prior art keywords
mannitol
weight
granulated composite
sorbitol
degree
Prior art date
Application number
Other languages
English (en)
Inventor
Yasuyuki Hirama
Naosuke Maruyama
Original Assignee
Shinetsu Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shinetsu Chemical Co filed Critical Shinetsu Chemical Co
Publication of IN2014DE03239A publication Critical patent/IN2014DE03239A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3239DE2014 2013-11-15 2014-11-10 IN2014DE03239A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013237000 2013-11-15

Publications (1)

Publication Number Publication Date
IN2014DE03239A true IN2014DE03239A (es) 2015-07-17

Family

ID=51951602

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3239DE2014 IN2014DE03239A (es) 2013-11-15 2014-11-10

Country Status (6)

Country Link
US (2) US20150141517A1 (es)
EP (1) EP2873415B1 (es)
JP (1) JP6307417B2 (es)
KR (1) KR102253849B1 (es)
CN (1) CN104644581A (es)
IN (1) IN2014DE03239A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016098459A1 (ja) * 2014-12-17 2016-06-23 株式会社ダイセル 遅延崩壊性粒子組成物
MX2021012033A (es) * 2019-04-03 2021-11-03 Astellas Pharma Inc Composicion farmaceutica.
EP4134103A4 (en) * 2020-04-10 2024-04-24 Japan Vam & Poval Co Ltd BINDER
JP7414668B2 (ja) * 2020-08-28 2024-01-16 信越化学工業株式会社 ポリビニルアルコール含有造粒物及び固形製剤
KR20230146800A (ko) 2022-04-13 2023-10-20 주식회사 산흥이지 도로교통 표지판의 각도 조절장치
CN116510026B (zh) * 2023-07-04 2023-09-19 山东天力药业有限公司 一种甘露醇复合药用辅料及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864406A (en) * 1973-04-25 1975-02-04 Suomen Sokeri Oy Process for the production of mannitol and sorbitol
WO2001064190A1 (fr) * 2000-03-01 2001-09-07 Eisai Co., Ltd. Comprimes se desagregeant rapidement contenant du poly(alcool de vinyle)
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
JP4279220B2 (ja) * 2004-09-09 2009-06-17 日信工業株式会社 複合材料及びその製造方法、複合金属材料及びその製造方法
TWI383809B (zh) * 2005-06-29 2013-02-01 Otsuka Pharma Co Ltd 含有西洛他唑（ｃｉｌｏｓｔａｚｏｌ）之口腔崩解粉末
KR101704156B1 (ko) * 2008-11-25 2017-02-07 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정을 제조하기 위한 혼합물
EP3031451B1 (en) * 2009-01-26 2018-03-07 Shin-Etsu Chemical Co., Ltd Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
CN102548542B (zh) * 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
JP6073543B2 (ja) * 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP5876418B2 (ja) 2010-12-28 2016-03-02 大鵬薬品工業株式会社 口腔内崩壊錠剤
JP2012236823A (ja) * 2011-04-28 2012-12-06 Fuji Chem Ind Co Ltd 耐湿安定性に優れた錠剤
CA2852417A1 (en) * 2011-10-21 2013-04-25 Takeda Pharmaceutical Company Limited Sustained-release preparation
WO2013098576A1 (en) * 2011-12-31 2013-07-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Immediate release pharmaceutical composition of valsartan
EP2674149B1 (en) * 2012-06-15 2017-10-04 Shin-Etsu Chemical Co., Ltd. Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation

Also Published As

Publication number Publication date
KR102253849B1 (ko) 2021-05-21
US20150141517A1 (en) 2015-05-21
CN104644581A (zh) 2015-05-27
JP2015117240A (ja) 2015-06-25
KR20150056474A (ko) 2015-05-26
EP2873415A1 (en) 2015-05-20
US11723872B2 (en) 2023-08-15
US20200038333A1 (en) 2020-02-06
EP2873415B1 (en) 2018-08-29
JP6307417B2 (ja) 2018-04-04

Similar Documents

Publication Publication Date Title
IN2014DE03239A (es)
MX2013007057A (es) Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos.
PH12016501196B1 (en) Composite formulation for oral administration comprising ezetimibe and rosuvastatin
EP4248766A3 (en) Smokeless oral tobacco product and preparation thereof
MX2015008427A (es) Proceso de granulacion en seco para producir composiciones de comprimidos de metformina y sus composiciones.
EA201391053A1 (ru) Таблетка, диспергируемая в ротовой полости
PH12016500793B1 (en) Soft pastilles containing turmeric extracts
WO2014114255A3 (zh) 一种定位速释生物粘附剂及应用
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
MX2019008865A (es) Preparaciones solidas que contienen tofogliflozina y proceso para producir las mismas.
PE20151024A1 (es) Composicion farmaceutica novedosa
NZ628451A (en) Dehydrated plant-derived products and methods for making the same
IN2015DN00427A (es)
WO2014144407A8 (en) Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
WO2014006636A3 (en) Stable compositions of fesoterodine
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
NZ715615A (en) Pharmaceutical compositions of ranolazine and dronedarone
NZ717101A (en) Partial melt co-crystallization compositions
PH12016502272A1 (en) Ceritinib formulation
CA3081484A1 (en) Finished fibrous structures and methods of their use and preparation
AU2013338098A8 (en) Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
WO2014108918A3 (en) Injectable antifungal formulation
TW201613620A (en) Jelly-like medicinal composition of potassium iodide
GEP201706769B (en) Composition of tiacumicin compounds
MY182080A (en) Method for manufacturing thickener composition